MASSDEVICE ON CALL — Despite repeated warnings and laments, the medical device tax implemented with healthcare reform hasn’t appeared to make much of a dent in the industry’s research & development activities, according to a small report.
Medical device makers and industry advocates have long warned that the 2.3% medical device tax enacted in the Affordable Care Act will damage the industry by taking funds from companies’ research & development budgets, but a look at 2013 spending for some of the industry’s biggest firms suggests that the tax had little impact.
Minnesota 2020 fellow Ronald Goldser cited a 2013 report from medtech industry lobby AdvaMed as well as R&D budgets for Medtronic (NYSE:MDT), St. Jude Medical (NYSE:STJ) and Boston Scientific (NYSE:BSX), concluding that "the ACA has had little impact on R&D expenditures."
Study finds cognitive impairments in kids who get cochlear implants
Researchers say that children with hearing loss who receive cochlear implants are higher risk of experiencing cognitive deficits, particularly in "executive functioning."
Former insurance CEO gets 3-year prison sentence for Medicaid fraud
Former WellCare Health Plans CEO Todd Farha was sentenced to 3 years in prison for his role in a Medicaid fraud scheme that falsely inflated behavioral health costs to avoid repaying unused premiums to state regulators.
More EEGs needed in the emergency room
Researchers call for greater use of EEG screening for emergency patients who present with seizures, saying that the tests may impact patient admission and care.
Docs spar over FDA’s anti-morcellation warning
The FDA’s controversial warning against hysterectomies using laparoscopic power morcellator has doctors arguing over the risks and benefits of the procedure.